ALKBH3 and Lung Cancer
Author Information
Author(s): Tasaki M, Shimada K, Kimura H, Tsujikawa K, Konishi N
Primary Institution: Nara Medical University School of Medicine
Hypothesis
ALKBH3 contributes to cell survival in human non-small-cell lung cancer.
Conclusion
ALKBH3 contributes significantly to cancer cell survival and may be a therapeutic target for human adenocarcinoma of the lung.
Supporting Evidence
- ALKBH3 was overexpressed in 75% of adenocarcinoma and squamous cell carcinoma samples.
- ALKBH3 positivity was statistically associated with recurrence-free survival in adenocarcinoma.
- Knockdown of ALKBH3 induced cell cycle arrest and senescence in lung adenocarcinoma cells.
Takeaway
ALKBH3 is a protein that helps lung cancer cells survive, and blocking it could help treat the disease.
Methodology
The study involved immunohistochemical analysis, siRNA transfection, and in vivo tumor growth assessment in mice.
Limitations
The study did not explore the effects of ALKBH3 on sensitivity to chemotherapeutic drugs.
Participant Demographics
The study included 86 specimens of human lung adenocarcinoma and 46 specimens of lung squamous cell carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website